Spectinomycin, sold under the tradename Trobicin among others, is an antibiotic useful for the treatment of gonorrhea infections. It is given by injection into a muscle. Common side effects include pain at the area of injection, rash, nausea, fever, and t + some more technical info Spectinomycin is an aminocyclitol antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit and blocking translocation, producing predominantly bacteriostatic activity against Neisseria gonorrhoeae. In clinical practice a single intramuscular dose is commonly used for uncomplicated gonococcal infections; the drug is largely excreted unchanged by the kidneys and displays a relatively short plasma half life. Laboratory and clinical considerations include activity against many strains of gonococcus including some penicillin resistant isolates, reduced risk of the ototoxicity classically associated with aminoglycosides, and the need for dose adjustments or alternative therapy in cases of severe renal impairment. Standard analytical and clinical monitoring covers injection site reactions, signs of hypersensitivity, and renal function when repeated dosing is required.
Parent: Spectinomycin
Parent: Spectinomycin
Parent: Spectinomycin
Parent: Spectinomycin
Parent: Spectinomycin
Parent: Spectinomycin
For active pharmaceutical ingredient control the spectinomycin material is characterized by an assay specification typically at or above 98.0 percent w w by validated assay, with related substances and impurities monitored by validated chromatographic methods. Common related compounds observed during synthesis, isolation and storage include acetylated derivatives, deaminated or oxidized products, deoxy or deshydro analogs, epimeric or diastereomeric forms, and residual process-related precursors and counterions such as sulfate. Typical QC acceptance criteria used in many dossiers and monographs are individual related substances controlled to low levels, commonly not more than 0.5 percent w w, with total related substances controlled to values often not exceeding about 1.5 percent w w, though exact limits depend on the pharmacopeial monograph and regulatory filing. Additional quality attributes include water content by Karl Fischer, residual solvents per ICH Q3C, and elemental impurities controlled per appropriate guidelines; identity and impurity profiles are confirmed by HPLC with PDA or MS detection, LC MS and NMR as needed.
Spectinomycin is used primarily to treat gonorrhea infections, especially uncomplicated urogenital gonorrhea, and is administered by intramuscular injection when recommended by clinical guidelines.
No. Spectinomycin is classified as an aminocyclitol antibiotic. It acts on the 30S ribosomal subunit similar to aminoglycosides in targeting protein synthesis but differs structurally and has a distinct safety and activity profile.
Yes. Spectinomycin is effective against many strains of Neisseria gonorrhoeae and has been used as a single intramuscular dose for treatment of uncomplicated gonorrhea, although local resistance patterns and current treatment guidelines should be consulted before use.
